EP0738151A1 - Behandlung unter berwendung von arachidonsaeurmetaboliten und teilchenfoermige zubereitungen - Google Patents

Behandlung unter berwendung von arachidonsaeurmetaboliten und teilchenfoermige zubereitungen

Info

Publication number
EP0738151A1
EP0738151A1 EP95908028A EP95908028A EP0738151A1 EP 0738151 A1 EP0738151 A1 EP 0738151A1 EP 95908028 A EP95908028 A EP 95908028A EP 95908028 A EP95908028 A EP 95908028A EP 0738151 A1 EP0738151 A1 EP 0738151A1
Authority
EP
European Patent Office
Prior art keywords
particle
disorder
endocytosable
metabolite
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP95908028A
Other languages
English (en)
French (fr)
Inventor
Andrew S. Janoff
David F. Eierman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elan Pharmaceuticals LLC
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of EP0738151A1 publication Critical patent/EP0738151A1/de
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP95908028A 1994-01-11 1995-01-11 Behandlung unter berwendung von arachidonsaeurmetaboliten und teilchenfoermige zubereitungen Ceased EP0738151A1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17973994A 1994-01-11 1994-01-11
US179739 1994-01-11
US20334194A 1994-02-28 1994-02-28
US203341 1994-02-28
PCT/US1995/000370 WO1995018620A1 (en) 1994-01-11 1995-01-11 Treatment using arachidonic acid metabolite and particulate formulations

Publications (1)

Publication Number Publication Date
EP0738151A1 true EP0738151A1 (de) 1996-10-23

Family

ID=26875610

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95908028A Ceased EP0738151A1 (de) 1994-01-11 1995-01-11 Behandlung unter berwendung von arachidonsaeurmetaboliten und teilchenfoermige zubereitungen

Country Status (7)

Country Link
EP (1) EP0738151A1 (de)
JP (1) JPH10507737A (de)
AU (1) AU682753B2 (de)
CA (1) CA2179986A1 (de)
FI (1) FI962806A7 (de)
NO (1) NO962911L (de)
WO (1) WO1995018620A1 (de)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995012389A1 (en) * 1993-11-04 1995-05-11 The Liposome Company, Inc. Multilamellar liposomal arachidonic acid metabolite formulations
WO1995013797A1 (en) * 1993-11-16 1995-05-26 The Liposome Company, Inc. Interdigitation-fusion liposomes containing arachidonic acid metabolites

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE176401T1 (de) * 1991-05-07 1999-02-15 Liposome Co Inc Liposomale prostaglandinformulierungen
DE4125255A1 (de) * 1991-07-31 1993-02-04 Knoll Ag Prostaglandin e (pfeil abwaerts)1(pfeil abwaerts)-formulierung

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995012389A1 (en) * 1993-11-04 1995-05-11 The Liposome Company, Inc. Multilamellar liposomal arachidonic acid metabolite formulations
WO1995012388A1 (en) * 1993-11-04 1995-05-11 The Liposome Company, Inc. Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
WO1995013797A1 (en) * 1993-11-16 1995-05-26 The Liposome Company, Inc. Interdigitation-fusion liposomes containing arachidonic acid metabolites

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LIU D, HUANG L: "Size homogeneity of a liposome preparation is crucial for liposome biodistribution in vivo", J LIPOSOME RESEARCH, vol. 2, 1992, pages 57 - 66, XP000246008 *
OSTRO M.J: "Liposomes", 1983, MARCEL DEKKER, INC., NEW YORK *
See also references of WO9518620A1 *

Also Published As

Publication number Publication date
AU1601895A (en) 1995-08-01
JPH10507737A (ja) 1998-07-28
CA2179986A1 (en) 1995-07-13
FI962806L (fi) 1996-09-10
FI962806A0 (fi) 1996-07-10
AU682753B2 (en) 1997-10-16
NO962911D0 (no) 1996-07-10
FI962806A7 (fi) 1996-09-10
NO962911L (no) 1996-09-03
WO1995018620A1 (en) 1995-07-13

Similar Documents

Publication Publication Date Title
US5925375A (en) Therapeutic use of multilamellar liposomal prostaglandin formulations
KR970005171B1 (ko) 아라키돈산 대사물질 관련 리포좀 제조방법 및 그 제제
EP0225130B1 (de) Liposomzusammensetzung
US4755388A (en) Liposome-encapsulated 5-fluoropyrimidines and methods for their use
EP0726764B1 (de) Multilamellare liposomformulierungen, die einen arachidsäuremetaboliten enthalten
US5811118A (en) Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
US5840328A (en) Treatment using arachidonic acid metabolite and particulate formulations
AU682753B2 (en) Treatment using arachidonic acid metabolite and particulate formulations
US5882678A (en) Interdigitation-fusion liposomes containing arachidonic acid metabolites
EP0729352B1 (de) Arachidonsäuremetaboliten enthaltende interdigitations-fusions-liposomen
WO1991006310A1 (en) Liposomal compositions
US20070071805A1 (en) Treatment of inflammation and vascular abnormalities of the eye
JP2634047B2 (ja) アルファトコフェロールをベースとした小胞体
JPH1160491A (ja) アムホテリシンｂ含有製剤
JPH0489430A (ja) 低血圧維持剤

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960711

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 19971222

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 31/557 A, 7A 61K 9/127 B, 7A 61K 47/00 B, 7A 61P 29/00 B, 7A 61P 9/02 B

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20020621